Successful anti-scavenger receptor class B type I (SR-BI) monoclonal antibody therapy in humanized mice after challenge with HCV variants with in vitro resistance to SR-BI-targeting agents

Koen Vercauteren, Naomi Van Den Eede, Ahmed Atef Mesalam, Sandrine Belouzard, Maria Teresa Catanese, Dorothea Bankwitz, Flossie Wong-Staal, Riccardo Cortese, Jean Dubuisson, Charles M Rice, Thomas Pietschmann, Geert Leroux-Roels, Alfredo Nicosia, Philip Meuleman

Research output: Contribution to journal › A1: Web of Science-article › peer-review

13 Downloads (Pure)

Fingerprint

Dive into the research topics of 'Successful anti-scavenger receptor class B type I (SR-BI) monoclonal antibody therapy in humanized mice after challenge with HCV variants with in vitro resistance to SR-BI-targeting agents'. Together they form a unique fingerprint.

Medicine & Life Sciences